Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v2-FR
Language English French
Date Updated 2023-01-25 2022-07-18
Drug Identification Number 02467135 02467135
Brand name ONIVYDE ONIVYDE
Common or Proper name Irinotecan Irinotecan
Company Name IPSEN BIOPHARMACEUTICALS CANADA INC IPSEN BIOPHARMACEUTICALS CANADA INC
Ingredients IRINOTECAN IRINOTECAN
Strength(s) 4.3MG 4.3MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 43mg/10mL 43mg/10mL
ATC code L01CE L01CE
ATC description
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2022-09-30
Actual discontinuation date
Remaining supply date 2022-09-30
Discontinuation status Reversed To be discontinued
Discontinuation decision reversal yes no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments